Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Infect Dis ; 194(12): 1761-70, 2006 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-17109350

RESUMEN

Methicillin-resistant Staphylococcus aureus (MRSA) remains a major problem in hospitals, and it is now spreading in the community. A single toxin, Panton-Valentine leukocidin (PVL), has been linked by epidemiological studies to community-associated MRSA (CA-MRSA) disease. However, the role that PVL plays in the pathogenesis of CA-MRSA has not been tested directly. To that end, we used mouse infection models to compare the virulence of PVL-positive with that of PVL-negative CA-MRSA representing the leading disease-causing strains. Unexpectedly, strains lacking PVL were as virulent in mouse sepsis and abscess models as those containing the leukotoxin. Isogenic PVL-negative (lukS/F-PV knockout) strains of USA300 and USA400 were as lethal as wild-type strains in a sepsis model, and they caused comparable skin disease. Moreover, lysis of human neutrophils and pathogen survival after phagocytosis were similar between wild-type and mutant strains. Although the toxin may be a highly linked epidemiological marker for CA-MRSA strains, we conclude that PVL is not the major virulence determinant of CA-MRSA.


Asunto(s)
Exotoxinas/fisiología , Leucocidinas/fisiología , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/patogenicidad , Absceso/microbiología , Animales , Animales no Consanguíneos , Toxinas Bacterianas/genética , Toxinas Bacterianas/metabolismo , Exotoxinas/genética , Exotoxinas/metabolismo , Femenino , Humanos , Inmunocompetencia , Leucocidinas/genética , Leucocidinas/metabolismo , Leucocitos Mononucleares/microbiología , Meticilina/farmacología , Resistencia a la Meticilina , Ratones , Ratones Pelados , Neutrófilos/microbiología , Mutación Puntual , Sepsis/microbiología , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/crecimiento & desarrollo , Staphylococcus aureus/metabolismo , Virulencia
2.
Am J Pathol ; 169(3): 927-42, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16936267

RESUMEN

Molecular mechanisms mediating group A Streptococcus (GAS)-host interactions remain poorly understood but are crucial for diagnostic, therapeutic, and vaccine development. An optimized high-density microarray was used to analyze the transcriptome of GAS during experimental mouse soft tissue infection. The transcriptome of a wild-type serotype M1 GAS strain and an isogenic transcriptional regulator knockout mutant (covR) also were compared. Array datasets were verified by quantitative real-time reverse transcriptase-polymerase chain reaction and in situ immunohistochemistry. The results unambiguously demonstrate that coordinated expression of proven and putative GAS virulence factors is directed toward overwhelming innate host defenses leading to severe cellular damage. We also identified adaptive metabolic responses triggered by nutrient signals and hypoxic/acidic conditions in the host, likely facilitating pathogen persistence and proliferation in soft tissues. Key discoveries included that oxidative stress genes, virulence genes, genes related to amino acid and maltodextrin utilization, and several two-component transcriptional regulators were highly expressed in vivo. This study is the first global analysis of the GAS transcriptome during invasive infection. Coupled with parallel analysis of the covR mutant strain, novel insights have been made into the regulation of GAS virulence in vivo, resulting in new avenues for targeted therapeutic and vaccine research.


Asunto(s)
Proteínas Bacterianas/genética , Regulación Bacteriana de la Expresión Génica/genética , Proteínas Represoras/genética , Infecciones de los Tejidos Blandos/genética , Infecciones Estreptocócicas/genética , Streptococcus pyogenes/genética , Factores de Virulencia/biosíntesis , Animales , Perfilación de la Expresión Génica , Inmunidad Innata/genética , Ratones , Estrés Oxidativo/genética , Infecciones de los Tejidos Blandos/metabolismo , Infecciones de los Tejidos Blandos/microbiología , Infecciones de los Tejidos Blandos/patología , Infecciones Estreptocócicas/metabolismo , Infecciones Estreptocócicas/patología , Infecciones Estreptocócicas/prevención & control , Vacunas Estreptocócicas/genética , Streptococcus pyogenes/patogenicidad , Transcripción Genética/genética , Vacunación
3.
Proc Natl Acad Sci U S A ; 102(5): 1679-84, 2005 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-15668390

RESUMEN

Many pathogenic bacteria produce extracellular DNase, but the benefit of this enzymatic activity is not understood. For example, all strains of the human bacterial pathogen group A Streptococcus (GAS) produce at least one extracellular DNase, and most strains make several distinct enzymes. Despite six decades of study, it is not known whether production of DNase by GAS enhances virulence. To test the hypothesis that extracellular DNase is required for normal progression of GAS infection, we generated seven isogenic mutant strains in which the three chromosomal- and prophage-encoded DNases made by a contemporary serotype M1 GAS strain were inactivated. Compared to the wild-type parental strain, the isogenic triple-mutant strain was significantly less virulent in two mouse models of invasive infection. The triple-mutant strain was cleared from the skin injection site significantly faster than the wild-type strain. Preferential clearance of the mutant strain was related to the differential extracellular killing of the mutant and wild-type strains, possibly through degradation of neutrophil extracellular traps, innate immune structures composed of chromatin and granule proteins. The triple-mutant strain was also significantly compromised in its ability to cause experimental pharyngeal disease in cynomolgus macaques. Comparative analysis of the seven DNase mutant strains strongly suggested that the prophage-encoded SdaD2 enzyme is the major DNase that contributes to virulence in this clone. We conclude that extracellular DNase activity made by GAS contributes to disease progression, thereby resolving a long-standing question in bacterial pathogenesis research.


Asunto(s)
Desoxirribonucleasas/metabolismo , Streptococcus pyogenes/inmunología , Streptococcus pyogenes/patogenicidad , Animales , Desoxirribonucleasas/genética , Modelos Animales de Enfermedad , Genotipo , Humanos , Cinética , Macaca fascicularis , Ratones , Mutación , Faringitis/microbiología , Reacción en Cadena de la Polimerasa , Infecciones Estreptocócicas/patología , Streptococcus pyogenes/genética
4.
Mol Microbiol ; 50(3): 835-43, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14617145

RESUMEN

Although the spirochetal protein OspA is capable of stimulating immune cells in a CD14- and TLR2-dependent manner, little is known about how TLR2 receptor complex ligands, such as OspA, are handled by the cell once delivered. We examine here the internalization of the fluorescently derivatized forms of both the full length OspA lipoprotein delivered as a recombinant soluble CD14 (rsCD14) complex and the corresponding lipohexapeptide given to the cells as an aggregate. Both forms of OspA are internalized in a similar manner to acetylated low density lipoprotein (AcLDL), a scavenger receptor ligand. Acetylated low density lipoprotein is capable of competing for internalization with OspA even when OspA is delivered as a rsCD14 complex. We observe co-localization of OspA with lysosomes but not with the Golgi complex. These phenomena are similar between RAW264.7 macrophages and endothelial cells but change drastically when the cells are deprived of serum. Upon serum starvation, OspA shows some localization to the Golgi apparatus whereas the lipohexapeptide remains on the cell surface. Inhibition of internalization of OspA via treatment with cytochalasin D or of the lipohexapeptide via serum starvation does not interfere with TNF induction activity, consistent with signalling from the cell surface.


Asunto(s)
4-Cloro-7-nitrobenzofurazano/análogos & derivados , Antígenos de Superficie/metabolismo , Proteínas de la Membrana Bacteriana Externa/metabolismo , Receptores de Lipopolisacáridos/metabolismo , 4-Cloro-7-nitrobenzofurazano/metabolismo , Animales , Antígenos de Superficie/efectos de los fármacos , Antígenos de Superficie/genética , Proteínas de la Membrana Bacteriana Externa/efectos de los fármacos , Proteínas de la Membrana Bacteriana Externa/genética , Vacunas Bacterianas , Células Cultivadas , Ceramidas/metabolismo , Medio de Cultivo Libre de Suero/farmacología , Citocalasina D/farmacología , Células Endoteliales/metabolismo , Aparato de Golgi/metabolismo , Receptores de Lipopolisacáridos/genética , Lipoproteínas/genética , Lipoproteínas/metabolismo , Lipoproteínas LDL/metabolismo , Lisosomas/metabolismo , Macrófagos/metabolismo , Glicoproteínas de Membrana/metabolismo , Ratones , FN-kappa B/efectos de los fármacos , FN-kappa B/metabolismo , Transporte de Proteínas , Receptores de Superficie Celular/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Receptor Toll-Like 2 , Receptores Toll-Like , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...